Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 23, 2000

View Archived Issues

Medigene, Aventis Enter Tumor Vaccine Deal Worth Up To $34M

Biovector, BioChem Pharma Align For Bacterium Vaccine

Epidauros Reports Discovery Of MDR-1 Gene Polymorphisms

Gemini Joins Genetics Effort Through Venture In Canada

CMV Research Shows NK Cells Have Role Controlling Infection

Chemunex Sees Further Gains In Acceptance Of ChemScan

MorphoSys, GPC Hit Milestone In Cancer Antibodies Program

Marketing Of Novartis' Bt Corn Blocked By German Authorities

New Debate Produces Further Delay In Framework For GMOs

Inpharmatica Identifies Target In Collaboration With Arrow

Israeli, Palestinian Scientists Unite For Research, Peace

Bavarian Nordic Moves Third Product Into Clinical Studies

Other News To Note

BTG Wins Israeli Approval For Recombinant Vaccine

Oxford Biomedica Signs 3rd Deal For Vector Technology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.